aid: excision-biotherapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/excision-biotherapeutics.png
name: Excision BioTherapeutics
description: >-
  Excision BioTherapeutics is a clinical-stage biotechnology company developing
  CRISPR-based gene-editing therapies intended to functionally cure serious
  viral infectious diseases. Its programs use multiplexed CRISPR/Cas approaches
  delivered via adeno-associated virus (AAV) to excise latent viral DNA from
  infected cells, with a lead candidate (EBT-101) targeting HIV and additional
  research directed at herpesviruses and hepatitis B. The company was surfaced
  as a portfolio company of Battery Ventures and added to the API Evangelist
  network. As a therapeutics company it does not currently publish a public
  developer API, SDK, or documentation surface; this profile therefore carries
  company identity and domain-security posture rather than API artifacts.
url: https://raw.githubusercontent.com/api-evangelist/excision-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- battery-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Gene Editing
- CRISPR
- Therapeutics
- Infectious Disease
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/excision-biotherapeutics-domain-security.yml
- type: Website
  url: https://www.excision.bio
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence